JAMA Internal Medicine : Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections

Interview with Robert Bals, MD, PhD, author of Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial, and Dan H. Barouch, MD, PhD, author of A Novel Approach for Preventing Respiratory Virus Infections. Hosted by Eve Rittenberg, MD.

Related Content:

• Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections
• A Novel Approach for Preventing Respiratory Virus Infections